Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 132 | 138 | 130 | 128 | 211 |
| Accounts receivable | -27 | 278 | 618 | -167 | -223 |
| Other Working Capital | 315 | 415 | 446 | 29 | -522 |
| Other Operating Activity | -2,077 | -3,126 | -3,146 | -1,162 | -271 |
| Operating Cash Flow | $-1,656 | $-2,294 | $-1,953 | $-1,172 | $-805 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 0 | -4 | -12 |
| Purchase Of Investment | N/A | N/A | 0 | -504 | N/A |
| Sale Of Investment | 45 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $45 | $N/A | $0 | $-508 | $-12 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,659 | 2,370 | 2,000 | 0 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 40 |
| Debt Repayment | -168 | -156 | -2,189 | -148 | -144 |
| Common Stock Issued | N/A | N/A | 0 | 2,545 | 2,155 |
| Financing Cash Flow | $1,491 | $2,214 | $-189 | $2,398 | $2,052 |
| Beginning Cash Position | 170 | 250 | 2,392 | 1,719 | 485 |
| End Cash Position | 50 | 170 | 250 | 2,436 | 1,719 |
| Net Cash Flow | $-120 | $-80 | $-2,142 | $718 | $1,234 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,656 | -2,294 | -1,953 | -1,172 | -805 |
| Capital Expenditure | N/A | N/A | N/A | -4 | -12 |
| Free Cash Flow | -1,656 | -2,294 | -1,953 | -1,176 | -817 |